SEC Company Response from Cabaletta Bio, Inc. (CABA) (CIK 0001759138) (CABA) — Nov 16, 2020
Cabaletta Bio, Inc. (CABA) (CIK 0001759138)
Date: Nov. 16, 2020 · CIK: 0001759138 · Accession: 0001193125-20-294729
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-250006
Letter
Cabaletta Bio, Inc.
2929 Arch Street, Suite 600
Philadelphia, Pennsylvania 19104
November 16, 2020
Via EDGAR Transmission
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
Cabaletta Bio, Inc.: Registration Statement on Form S-3 filed November 10, 2020
(File No. 333-250006)
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Cabaletta Bio, Inc. (the “Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to November 18, 2020, at 4:01 pm Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.
If you have any questions regarding this request, please contact Gabriela Morales-Rivera, Esq. of Goodwin Procter LLP at (617) 570-1329.
Sincerely,
CABALETTA BIO, INC.
Show Raw Text
CORRESP
1
filename1.htm
CORRESP
Cabaletta Bio, Inc.
2929 Arch Street, Suite 600
Philadelphia, Pennsylvania 19104
November 16, 2020
Via EDGAR Transmission
Securities and Exchange Commission
Division of Corporation
Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
Cabaletta Bio, Inc.: Registration Statement on Form S-3 filed November 10, 2020
(File No. 333-250006)
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), Cabaletta Bio, Inc. (the
“Company”) hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to November 18, 2020, at 4:01 pm Eastern Time, or as soon
thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it
is aware of its responsibilities under the Act.
If you have any questions regarding this request, please contact Gabriela Morales-Rivera,
Esq. of Goodwin Procter LLP at (617) 570-1329.
Sincerely,
CABALETTA BIO, INC.
/s/ Steven Nichtberger, M.D.
Steven Nichtberger, M.D.
President and Chief
Executive Officer
cc:
J. Brian Stalter, Esq., Cabaletta Bio, Inc.
Mitchell S. Bloom, Esq., Goodwin Procter LLP
Michael Minahan, Esq., Goodwin Procter LLP
Gabriela Morales-Rivera, Esq., Goodwin Procter LLP